Molecular Imaging: Page 45

AC Immune gets payment for tau PET tracer trial

By AuntMinnieEurope.com staff writers

Swiss biopharmaceutical company AC Immune has received a milestone payment from partner Life Molecular Imaging following the start of a phase II study of the tau PET tracer PI-2620.

September 16, 2019

AuntMinnieEurope.com Molecular Imaging Insider

By Wayne Forrest

September 15, 2019

Training in FDG-PET/CT advances lung cancer outcome

By Wayne Forrest

Additional training in FDG-PET/CT to monitor concurrent chemotherapy for patients with stage III non-small cell lung cancer can significantly extend both overall and progression-free survival, according to an international study published in the October issue of European Journal of Nuclear Medicine and Molecular Imaging.

September 15, 2019

Swiss cast new light on prostate cancer analysis

By Wayne Forrest

Researchers from Zurich have found gallium-68 prostate-specific membrane antigen offers better sensitivity, while multiparametric MRI provides better specificity, especially when determining tumor cell spread beyond the lymph node capsule or when prostate cancer extends into the seminal vesicles.

September 15, 2019

Novel PET method advances in traumatic brain injury

By Wayne Forrest

A research team from the U.K. and Sweden has used dynamic flortaucipir-PET imaging to show that single moderate-to-severe traumatic brain injury can trigger signs of accumulation of neurodegenerative tau protein and lead to cognitive decline.

September 12, 2019

Merging PET and MRI assists in large-vessel vasculitis

By Wayne Forrest

French investigators have combined contrast-enhanced anatomic assessments of MRI with the quantitative measurement of FDG uptake in PET to accurately characterize and differentiate between inflammation and fibrosis in the aortic walls and auxiliary branches of patients with large-vessel vasculitis.

September 11, 2019

Ga-68 PMSA PET/CT aids in prostate cancer recurrence

By Wayne Forrest

Italian researchers have created a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/CT-based model to accurately predict which prostate cancer patients are likely to show recurrence. Their study was published on 6 September in the European Journal of Nuclear Medicine and Molecular Imaging.

September 11, 2019

ESR seeks to demystify biomarkers

By Philip Ward

The European Society of Radiology (ESR) has issued a detailed set of recommendations designed to promote the use of validated imaging biomarkers as clinical decision-making tools. Prof. Nandita deSouza explains the rationale behind this initiative.

September 8, 2019

EANM publishes thyroid guideline

By AuntMinnieEurope.com staff writers

The European Association of Nuclear Medicine (EANM) has announced the release of a guideline for scintigraphic evaluation of the thyroid. The guideline was published online on 7 August in the European Journal of Nuclear Medicine and Molecular Imaging.

September 5, 2019

Shine names VP of European operations

By AuntMinnieEurope.com staff writers

Medical isotope firm Shine Medical Technologies has appointed Harrie Buurlage as vice president (VP) of European operations.

September 3, 2019

AC Immune receives PET tracer grant

By AuntMinnieEurope.com staff writers

Swiss biopharmaceutical company AC Immune has received another grant from the Michael J. Fox Foundation for Parkinson's Research to advance the company's alpha-synuclein (a-syn) PET tracer program.

September 3, 2019

Eckert & Ziegler signs deal with Alpha Tau Medical

By AuntMinnieEurope.com staff writers

Isotope technology firm Eckert & Ziegler has signed a multiyear agreement to supply Israeli radiation therapy technology developer Alpha Tau Medical with thorium-228, a radioisotope used to produce Alpha Tau's Alpha DaRT therapy for solid tumors.

September 3, 2019

Previous Page

Page 45 of 121

Next Page